A Calcagno, N Coppola, L Sarmati, M Tadolini, R Parrella, A Matteelli, N Riccardi, M Trezzi, A Di Biagio, V Pirriatore, A Russo, G Gualano, E Pontali, L Surace, E Falbo, J Mencarini, F Palmieri, A Gori, M Schiuma, G Lapadula, D Goletti
BACKGROUND: Non-tuberculous mycobacteria (NTM) are generally free-living organism, widely distributed in the environment, with sporadic potential to infect. In recent years, there has been a significant increase in the global incidence of NTM-related disease, spanning across all continents and an increased mortality after the diagnosis has been reported. The decisions on whether to treat or not and which drugs to use are complex and require a multidisciplinary approach as well as patients' involvement in the decision process...
February 8, 2024: Infection